From the Blood Journals

From the Blood Journals

Research from the Blood family of journals: Blood and Blood Advances

Choosing Between Strategies for Managing Fetal or Neonatal Alloimmune Thrombocytopenia

Wednesday, March 1st, 2017
For women diagnosed with fetal and neonatal alloimmune thrombocytopenia (FNAIT), a noninvasive strategy of weekly intravenous immunoglobulin infusion (IVIg) and corticosteroids could help prevent...

Self-Reporting Significantly Overestimates Treatment Adherence in Pediatric Patients With Acute Lymphocytic Leukemia

Wednesday, March 1st, 2017
Maintenance therapy with oral 6-mercaptopurine (6MP) for pediatric patients with acute lymphocytic leukemia (ALL) is crucial for maintaining a durable remission, and poor adherence...

Radiation Dose and Use of Anthracyclines Increase Risk of Heart Failure in Hodgkin Lymphoma...

Wednesday, March 1st, 2017
Previous studies have linked mediastinal radiotherapy (RT) and/or anthracycline-containing chemotherapy with increased risk of coronary heart disease, valvular heart disease, and heart failure (HF)...

Report Questions the Validity of Rivaroxaban Trial

Friday, February 24th, 2017
An investigation by the British Journal of Medicine (BMJ) has raised questions about the validity of the pivotal ROCKET-AF trial, the results of which formed the...

Examining Hemoglobin Variants and Geographic Variability of Sickle Cell Trait and Sickle Cell Disease...

Wednesday, February 22nd, 2017
Results from the prospective Uganda Sickle Surveillance Study (US3), which was created through a partnership among the Uganda Ministry of Health, Makerere University, and...

Where Does Clofarabine Fit in the Treatment of Patients With Acute Myeloid Leukemia?

Thursday, February 2nd, 2017
Adding clofarabine – a second-generation nucleoside analogue – to a standard induction regimen reduced the risk of relapse for patients with newly diagnosed acute...

Long-Term Analysis Identifies Encouraging Trends in Hemophilia A Care

Thursday, February 2nd, 2017
From 1999 to 2010, bleeding events among U.S. patients with hemophilia A have dropped dramatically, coinciding with a marked increase in the use of...

Assessing Lenalidomide Plus Rituximab for Patients With MALT Lymphoma

Thursday, February 2nd, 2017
Patients with advanced mucosa-associated lymphoid tissue (MALT) lymphoma are often treated with chemotherapy-based regimens; however, because of the indolent course of the disease, researchers...

Combining ATRA With ATO With or Without Gemtuzumab Ozogamicin Produces Durable Responses in Patients...

Monday, January 23rd, 2017
The combination of all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO), with or without the addition of gemtuzumab ozogamicin (GO), is a safe and effective...

A New Topical Treatment for Cutaneous T-Cell Lymphoma

Friday, January 20th, 2017
The investigational topical drug resiquimod was safe and effective in clearing treated and untreated skin lesions in patients with early-stage cutaneous T-cell lymphoma (CTCL),...
Advertisement

Current Issue

March 2017, Volume 3, Issue 4

This issue takes a look at diversity in the medical education system, provides a hematology drug pipeline update, and more.